Caseous Lymphadenitis (CL)

Caseous Lymphadenitis (CL) is a chronic, contagious bacterial disease of sheep and goats caused by Corynebacterium pseudotuberculosis, characterized by the formation of abscesses in lymph nodes and internal organs. The disease takes its name from the characteristic caseous (cheese-like) appearance of the thick, greenish-white pus found within the abscesses. CL is one of the most economically important diseases affecting small ruminants worldwide, causing significant losses through reduced productivity, carcass condemnation, premature culling, and trade restrictions. The chronic nature of infection and difficulty of eradication make CL a persistent challenge for sheep producers globally.

CL affects sheep of all ages and breeds, though the disease typically becomes apparent in animals over one year of age as abscesses take time to develop to detectable size. Both external (superficial) and internal (visceral) forms of the disease occur, with external abscesses being more easily detected but internal involvement causing greater production impacts. The disease is widespread in sheep-producing regions throughout the world, with prevalence varying considerably between regions and individual flocks. In some endemic areas, the majority of adult sheep may be infected, while careful biosecurity can maintain flocks essentially free of the disease.

The economic impact of CL extends across multiple aspects of sheep production. External abscesses cause carcass trim and condemnation at slaughter, directly reducing returns from meat sales. Internal disease leads to the "thin ewe syndrome" where chronically infected animals fail to maintain condition despite adequate nutrition, eventually requiring premature culling. Wool quality and quantity may be reduced in affected animals. Perhaps most significantly, CL infection limits the marketability of breeding stock, as conscientious buyers increasingly require evidence of CL-free status. Export markets and show animals face particular scrutiny for this disease.

Management of CL requires a comprehensive approach combining prevention, detection, and strategic removal of infected animals. While treatment of individual animals is possible, it is rarely economically justified and does not eliminate infection. Vaccination is available in some regions and provides partial protection, reducing severity and spread rather than preventing infection completely. Biosecurity measures to prevent introduction and limit spread within infected flocks form the foundation of control programs. Long-term commitment to testing, culling, and prevention can achieve significant reduction in disease prevalence, though complete eradication from an infected flock is challenging.

The causative agent of CL is Corynebacterium pseudotuberculosis, a gram-positive, facultatively intracellular bacterium capable of surviving within host macrophages and establishing chronic infection. The organism produces an exotoxin called phospholipase D that damages cell membranes and allows the bacterium to spread from the initial infection site through the lymphatic system to regional lymph nodes. The ability to survive within host immune cells and form walled-off abscesses protects the bacterium from both immune responses and antibiotic treatment, explaining the chronic, persistent nature of CL infections. Two biovars of C. pseudotuberculosis exist, with biovar ovis primarily affecting sheep and goats and biovar equi more commonly infecting horses.

Transmission of CL occurs primarily through contamination of wounds with pus from ruptured abscesses. Shearing cuts represent the most significant source of wound contamination in sheep flocks, with infected equipment spreading bacteria from animal to animal during shearing procedures. Dipping, docking, castration, and other management procedures that create wounds or share equipment between animals similarly facilitate transmission. Environmental contamination from ruptured abscesses allows indirect transmission, as the organism can survive for extended periods in soil, on fencing, and in buildings. Direct contact with draining abscesses or inhalation of contaminated aerosols represents additional transmission routes.

Environmental factors significantly influence CL transmission and persistence. The bacterium survives remarkably well in the environment, persisting for months in contaminated soil, wooden posts, and accumulated organic matter. Warm, moist conditions favor survival, while direct sunlight and desiccation reduce environmental persistence. Yards, shearing sheds, and other areas where sheep congregate and where contamination accumulates represent high-risk locations. Once established on a property, environmental contamination creates ongoing exposure risk that is difficult to eliminate.

Risk factors for CL introduction and spread relate to animal movements, management practices, and biosecurity measures. Purchasing animals from infected flocks or those with unknown CL status represents the primary route of introduction to previously clean flocks. Shared shearing equipment and contractors moving between properties spread infection between flocks. High stocking density increases contact between animals and exposure to environmental contamination. Wounds from any source, including those from rough handling, fighting, or environmental hazards, provide entry points for the organism. Age is a risk factor for clinical disease, with older animals having had more exposure opportunities and time for abscesses to develop.

The pathophysiology of CL involves initial entry of bacteria through skin wounds, followed by uptake by macrophages and spread through lymphatic vessels to regional lymph nodes. Within the lymph nodes, the bacteria establish infection by surviving within macrophages and recruiting additional immune cells that form the characteristic abscess. The immune response walls off the infection site with fibrous tissue, creating the typical onion-like concentric layers seen in mature CL abscesses. Some bacteria escape the primary abscess site and spread via the bloodstream to establish secondary abscesses in internal organs, particularly the lungs, liver, and kidneys. This internal dissemination results in the more serious visceral form of CL.

Early warning signs of CL are often subtle or absent, as the disease develops slowly and abscesses take months to years to reach detectable size. Initial infection following wound contamination typically produces no obvious clinical signs. The first indication of CL in a flock may be detection of enlarged lymph nodes during routine handling or observation of draining abscesses. In endemic flocks, the presence of CL often becomes apparent only when significant numbers of animals develop visible abscesses or when chronic wasting is investigated. Producers should maintain high vigilance during handling procedures to detect the subtle swellings that indicate early abscess development.

External or superficial CL manifests as abscesses in the lymph nodes that drain the skin and subcutaneous tissues. The most commonly affected nodes include the prescapular (in front of the shoulder), prefemoral (in the flank), and submandibular (under the jaw) lymph nodes. Affected nodes become progressively enlarged, initially feeling firm but becoming fluctuant as the caseous content develops. External abscesses may reach considerable size, sometimes as large as a tennis ball or larger. Eventually, mature abscesses may rupture through the skin, releasing the characteristic thick, greenish-white, odorless pus and contaminating the environment with millions of bacteria.

Behavioral changes associated with CL are generally limited unless internal involvement is extensive. Animals with superficial abscesses typically behave normally and show no obvious signs of illness. Those with internal disease may show progressive weight loss despite adequate appetite, a condition sometimes called "thin ewe syndrome." Reduced activity and exercise intolerance may develop when lung abscesses compromise respiratory function. Affected animals may be more susceptible to other diseases due to chronic immune stimulation and reduced overall condition. In advanced cases with widespread internal involvement, general malaise and depression may be observed.

Physical signs of CL depend on the location and extent of infection. Palpable enlargement of superficial lymph nodes is the hallmark finding in external disease. Multiple nodes may be affected simultaneously or sequentially as the disease progresses. Ruptured abscesses leave scarred areas on the skin that may be detected during examination. Internal CL produces less specific physical findings, with weight loss and poor body condition being the primary observable signs. Respiratory involvement may cause increased breathing rate and effort, coughing, and exercise intolerance. Extensive internal disease may cause detectable abnormalities on thoracic or abdominal palpation, though this is unusual.

Symptom progression in CL follows the slow development of abscesses over months to years. Initial infection is clinically silent. Lymph node enlargement becomes detectable as abscesses grow, typically requiring at least several months from infection. Abscesses continue to enlarge slowly, with periodic drainage and reformation occurring in some cases. Internal spread, when it occurs, takes months to years to produce clinical effects. Weight loss from internal disease develops gradually, often becoming apparent only in comparison to healthy flockmates. The chronic, slowly progressive nature of CL means that years may pass between infection and recognition of clinical disease.

Emergency symptoms in CL are uncommon given the chronic nature of the disease, but certain presentations warrant urgent veterinary attention. Difficulty breathing from extensive pulmonary involvement requires immediate assessment. Large abscesses in locations that could compromise airways or major blood vessels need evaluation. Secondary infections of ruptured abscesses causing cellulitis or septicemia demand prompt treatment. Sudden death can occur if abscesses rupture into body cavities or major blood vessels, though this is rare. Any animal showing acute deterioration or unusual severity of signs should be examined promptly to rule out complications.

Clinical examination for CL focuses on systematic palpation of all superficial lymph nodes during routine handling. The prescapular, prefemoral, popliteal, submandibular, and parotid nodes should be assessed bilaterally for enlargement, asymmetry, or abscess formation. Normal lymph nodes are small and difficult to palpate, while affected nodes are enlarged, firm or fluctuant, and often asymmetric when compared side to side. The presence of scars from previous abscess rupture indicates prior infection. Body condition scoring helps identify animals with possible internal disease. Careful clinical examination during shearing provides an ideal opportunity for systematic CL screening.

Laboratory diagnosis of CL can confirm clinical suspicions and is essential for definitive diagnosis. Culture of abscess contents readily grows C. pseudotuberculosis on appropriate media, providing definitive identification. Sample collection should be performed carefully to avoid environmental contamination, with pus aspirated from intact abscesses using sterile technique. Serological testing using ELISA or other antibody detection methods can identify exposed animals, including those with internal disease that lack palpable abscesses. Serology is particularly valuable for screening purposes and identifying infected animals before clinical signs develop. However, serological tests have limitations including potential for false negatives in early infection and false positives from environmental exposure.

Differential diagnosis for CL includes other causes of lymph node enlargement and abscess formation in sheep. Injection site reactions and abscesses can produce swellings that mimic CL, though these typically occur at specific injection sites rather than in lymph nodes. Other bacterial infections causing abscesses, including those caused by Arcanobacterium pyogenes, may appear similar clinically. Lymphoma and other neoplastic conditions cause lymph node enlargement but typically affect multiple nodes symmetrically. Parasitic cysts occasionally mimic abscesses. Tuberculosis, though uncommon in sheep, produces similar lesions and should be considered where this disease occurs. Definitive diagnosis through culture or serology distinguishes CL from other conditions.

Herd-level diagnostics are essential for effective CL control programs. Whole-flock serological testing identifies the prevalence of infection and detects animals with internal disease not apparent on clinical examination. Strategic testing of different age groups provides information about ongoing transmission within the flock. Testing before and after shearing can help determine whether transmission is occurring during this high-risk procedure. Pre-purchase testing of incoming animals prevents introduction of infection. Regular monitoring through clinical examination and periodic serological surveys tracks the effectiveness of control programs over time.

Emergency treatment for CL is rarely indicated given the chronic nature of the disease, but acute complications may require intervention. Large abscesses causing discomfort or threatening to rupture in inappropriate locations may be surgically drained and flushed. Careful handling of abscess contents is essential to prevent environmental contamination, with pus being collected and disposed of by burning or deep burial. Systemic antibiotics may be administered to animals with secondary infections or septicemic complications. Anti-inflammatory medications provide symptomatic relief when indicated. Emergency drainage should be followed by appropriate wound management and isolation of affected animals.

Medical management of CL with antibiotics is possible but rarely achieves cure due to the protected intracellular location of bacteria and the walled-off nature of abscesses. Extended courses of antibiotics including penicillin, tetracyclines, or tilmicosin may reduce bacterial shedding and slow disease progression. However, antibiotic treatment does not eliminate established abscesses or prevent future recurrence. Antibiotic therapy is generally not cost-effective for commercial animals and raises concerns about withdrawal periods and antimicrobial resistance. Treatment may be considered for valuable breeding stock or animals with acute complications, with clear understanding of limitations.

Surgical treatment involving complete excision of abscesses has been attempted with limited success. Complete removal of intact abscesses without rupture, including the surrounding capsule, can potentially cure localized infections. However, the procedure is technically challenging, particularly for deep abscesses, and carries risk of abscess rupture with massive environmental contamination. Internal abscesses cannot be surgically removed. Even successful removal of visible abscesses does not guarantee elimination of infection, as additional small abscesses may be present. Surgical treatment is rarely practical or cost-effective in commercial sheep production.

Supportive care for CL-affected animals focuses on maintaining overall health and productivity as long as economically viable. Ensuring adequate nutrition supports body condition and immune function. Reducing stress through appropriate handling and housing benefits chronically infected animals. Treatment of secondary conditions maintains quality of life. Isolation of animals with draining abscesses prevents environmental contamination and transmission to flockmates. Supportive management allows continued productivity while control programs progress.

Herd-level treatment strategies recognize that individual animal treatment is impractical and ineffective for controlling CL at the flock level. Strategic culling of affected animals, particularly those with draining abscesses or poor body condition, removes sources of infection. Vaccination reduces disease severity and transmission even if it does not prevent infection. Management changes to reduce transmission opportunities, particularly during shearing, complement culling and vaccination. This integrated approach offers the only realistic path to reducing CL prevalence in affected flocks.

Treatment decisions for CL must consider the goals of disease control, economic factors, and individual animal value. For most commercial sheep, culling infected animals is more practical than treatment. Valuable breeding stock may warrant attempted treatment despite poor cure rates. Animals with extensive internal disease should be culled on welfare grounds regardless of value. The economics of extended antibiotic treatment, including drug costs, withdrawal periods, and low success rates, rarely favor medical management. Decision frameworks should prioritize flock-level control over individual animal treatment in most situations.

Recovery from CL in the sense of complete cure is uncommon due to the persistent nature of infection. Animals treated medically may show improvement in clinical signs and reduction in abscess size, but typically remain infected. Spontaneous resolution of abscesses occasionally occurs, though the underlying infection usually persists. Animals that have had abscesses surgically removed may have prolonged periods without clinical signs but can develop new abscesses from persistent internal infection. True recovery with elimination of C. pseudotuberculosis infection is difficult to confirm and should be assumed to be rare.

Post-treatment monitoring of CL cases involves regular palpation of lymph nodes to detect new or recurring abscesses. Serological testing may track antibody levels, though interpretation is complicated by persistent seropositivity in most infected animals. Body condition monitoring identifies animals with progressive internal disease. Animals that have been treated should be considered potentially infectious and managed accordingly, including isolation from clean animals and careful management of any draining material. Ongoing monitoring helps identify treatment failures requiring culling.

Prognosis for individual animals with CL depends on disease extent and production goals. Animals with limited external disease often remain productive for extended periods despite infection. Extensive internal involvement carries a poor prognosis for long-term productivity, with progressive weight loss and eventual culling being typical outcomes. Prognosis for cure is poor regardless of disease extent due to persistent infection. The prognosis for maintaining animals in acceptable production until planned culling is generally fair for external disease but guarded for significant internal involvement.

Return to production considerations for CL-affected animals must balance ongoing infection risk against individual productivity. Infected animals continue shedding bacteria intermittently, representing ongoing transmission risk to flockmates. Meat production is affected by carcass condemnation if abscesses are present at slaughter. Wool production may be acceptable if body condition is maintained. Breeding use of infected animals perpetuates infection through direct transmission to offspring and flock contamination. Most control programs recommend against returning treated animals to breeding roles, instead maintaining them in terminal production systems or culling.

Vaccination protocols for CL provide partial protection that reduces disease severity and transmission rates. Commercial vaccines containing C. pseudotuberculosis antigens and phospholipase D toxoid are available in some regions. Primary vaccination requires two doses administered 4-6 weeks apart, with annual boosters maintaining immunity. Vaccination does not prevent infection but reduces abscess development and bacterial shedding in infected animals. This reduction in shedding decreases environmental contamination and transmission to susceptible flockmates. Vaccination is most valuable as one component of comprehensive control programs rather than a standalone prevention measure.

Biosecurity measures to prevent CL introduction should be the primary focus for clean flocks. Purchasing animals only from flocks with documented CL-free status or with negative individual testing dramatically reduces introduction risk. Quarantine of all purchased animals with clinical examination and serological testing before mixing with the main flock provides security. Avoiding shared shearing equipment and contractors from unknown CL status flocks prevents indirect introduction. Fence-line contact with potentially infected neighbors should be minimized. These measures require commitment but can maintain CL-free status indefinitely.

Shearing hygiene is critical for reducing CL transmission within infected flocks and preventing spread between properties. Disinfection of shearing equipment between animals, using products effective against C. pseudotuberculosis, reduces transmission via wound contamination. Shearing clean or young animals before older or known-infected animals limits exposure. Hand washing and equipment disinfection by shearing contractors between properties prevents between-flock transmission. Careful shearing technique that minimizes cuts reduces wound contamination opportunities. Investment in shearing hygiene provides substantial returns through reduced CL transmission.

Management practices supporting CL prevention reduce wound contamination opportunities and environmental challenge. Prompt treatment of any wounds reduces infection entry opportunities. Maintaining facilities to minimize injury from rough surfaces or protruding objects prevents wounds. Avoiding overcrowding reduces contact between animals and competition-related injuries. Regular removal of organic matter and use of appropriate disinfectants reduces environmental contamination. Isolation or culling of animals with draining abscesses immediately upon detection prevents massive environmental contamination.

Quarantine and testing protocols provide the foundation for CL control programs. All purchased animals should be quarantined for a minimum of 30 days with clinical examination and serological testing before flock entry. Annual or biannual serological testing of the main flock monitors program effectiveness and identifies new infections. Testing before sales provides documentation for buyers and supports premium pricing for clean stock. Pre-shearing testing identifies infected animals for separate handling. Strategic testing programs tailored to individual flock circumstances maximize the value of diagnostic investment.

Daily management and monitoring for CL integrates disease surveillance into routine husbandry activities. Regular observation of animals identifies those with visible swellings or draining abscesses. Any animal found with a draining abscess should be immediately isolated and the abscess managed to prevent environmental contamination. Recording of affected individuals builds understanding of disease distribution and trends. Monitoring body condition identifies animals potentially affected by internal disease. Training all personnel to recognize CL signs ensures consistent surveillance.

Housing and environmental management in CL-affected flocks focuses on reducing contamination and transmission opportunities. Isolation facilities allow separation of animals with draining abscesses from the main flock. Regular cleaning and disinfection of handling facilities, particularly shearing sheds and yards, reduces environmental bacterial loads. Disposal of abscess contents by burning or deep burial prevents environmental seeding. Replacement of wooden posts and structures that cannot be effectively disinfected may be necessary in heavily contaminated areas. Maintaining dry, clean conditions reduces bacterial survival.

Herd health programs for CL integrate testing, culling, vaccination, and management into comprehensive control strategies. Program design should reflect flock-specific circumstances including current prevalence, production system, and goals. Low-prevalence flocks may pursue eradication through testing and culling, while high-prevalence flocks may focus initially on reducing transmission through vaccination and management. Regular veterinary review evaluates progress and adjusts strategies as needed. Long-term commitment over multiple years is essential for meaningful prevalence reduction.

Record keeping and monitoring systems support effective CL management through tracking of individual animal status and flock-level trends. Individual animal records should document any abscess detections, test results, treatments, and outcomes. Flock-level records track prevalence trends over time and evaluate control program effectiveness. Recording of CL-related culling and carcass condemnations documents economic impact. Analysis of data informs management decisions and demonstrates progress to buyers of breeding stock.

Economic considerations for CL management involve substantial initial investment for potential long-term returns. Testing programs require ongoing expenditure but provide essential information for control. Culling of valuable infected animals represents immediate losses against future gains from disease reduction. Vaccination costs are offset by reduced transmission and disease severity. Premium pricing for documented clean status breeding stock rewards investment in control programs. Comprehensive economic analysis should guide program design and justify continued investment in CL management.

All sheep breeds are susceptible to CL, with no breed demonstrating significant resistance to Corynebacterium pseudotuberculosis infection. Disease prevalence varies between flocks and regions based on management, biosecurity, and historical exposure rather than breed susceptibility. Fine-wool breeds may suffer particular economic impact when CL affects wool quality or when infected animals fail to maintain the body condition necessary for optimal fleece production. Meat breeds experience losses through carcass condemnation when abscesses are detected at slaughter. All breed types benefit equally from vaccination and biosecurity measures.

Production type considerations influence CL impact and management priorities. Breeding flocks face significant consequences when CL limits the marketability of stock, as buyers increasingly demand CL-free status. Commercial meat production flocks experience losses through carcass condemnation and reduced growth rates in affected animals. Wool-producing operations may see quality impacts in chronically infected animals. Stud and show flocks face particular scrutiny and may suffer severe reputational damage from CL detection. Each production system requires tailored management approaches balancing control investment against specific economic impacts.

Genetic selection for CL resistance has received limited research attention, with no established genetic markers or breeding programs for resistance. Individual animal variation in disease susceptibility likely exists but is confounded by exposure variation. Selection programs appropriately focus on culling infected animals, which removes both the infection and any genetic predisposition toward susceptibility. Future research may identify genetic factors influencing resistance to infection or disease progression. Currently, genetic improvement for CL control relies on eliminating infected animals and maintaining rigorous biosecurity rather than selecting for resistance traits.

Commonly co-occurring conditions with CL relate to the chronic immune stimulation and reduced condition associated with longstanding infection. Chronic weight loss predisposes to pregnancy toxemia in late gestation. Reduced immune function may increase susceptibility to parasitic infections and their effects. Secondary bacterial infections can complicate draining abscesses. Animals weakened by extensive internal CL may be more susceptible to pneumonia and other infectious diseases. The chronic nature of CL infection means affected animals often encounter additional health challenges during their lifetime.

Conditions with similar clinical presentations must be differentiated from CL. Injection site abscesses occur at specific locations and have different content characteristics. Abscesses caused by other bacteria including Arcanobacterium pyogenes may appear similar but typically produce different pus consistency and odor. Lymphoma causes lymph node enlargement but affects multiple nodes symmetrically and has different cytology. Actinobacillosis and actinomycosis cause abscesses but typically in different locations. Orf can cause lesions around the head that might be confused with CL abscesses. Definitive diagnosis through culture or serology clarifies uncertain cases.

Complications and sequelae of CL develop over the chronic course of infection. Thin ewe syndrome from extensive internal involvement leads to premature culling. Respiratory compromise from pulmonary abscesses causes exercise intolerance and increased susceptibility to pneumonia. Rare complications include abscess rupture into body cavities causing acute illness. Chronic immune stimulation may affect responses to vaccination against other diseases. Scarring from healed abscesses can affect hide quality. Understanding potential complications informs management decisions for individual animals and emphasizes the value of prevention.